$GECC

Great Elm Capital Corp. Announces SECOND Quarter 2026 Financial Results

Great Elm Capital Corp. (GECC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Great Elm Capital Corp. Announces SECOND Quarter 2026 Financial Results Company to Host Conference Call and Webcast at 8:30 AM ET on August 6, 2026 GECC’s Investment Adviser Waives Incentive Fees Totaling $0.9 million or $0.06 Per Share for the Quarter Ended June 30,

Original reporting
Published Aug 5, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$GECC
Bullish
medium confidence
Mentioned
$GECC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GECCBullishMed
01

Why it matters

The 8-K provides a full 2Q26 snapshot: NAV growth, NII per share, dividend declaration, and concrete balance-sheet actions (note calls, revolver extension, liquidity).

02

Market read

Traders can reassess GECC’s income coverage, NAV trend, and near-term credit-risk via disclosed liquidity and debt refinancing actions.

03

What to watch

The filing highlights less than 1% nonaccrual, but traders may still focus on portfolio credit performance trends beyond the quarter and the impact of called notes on future interest expense.

Relevance 7/10Novelty 7/10Timing: after-hours filing for 2Q26 results, conference call scheduled Aug 6, 2026 8:30 AM ET

Background

Great Elm Capital Corp. (GECC) is a business development company that reports quarterly results on NAV, NII, distributions, and capital structure.

Company-level read

Ticker impact

$GECCBullishMedium confidence
Context

GECC reported 2Q26 results, raised NAV to $7.95/share, declared a $0.25 dividend, and extended revolver maturity to 2029 while calling high-cost notes.

Expected impact

Likely supportive for near-term sentiment, with follow-through dependent on whether NII sustains dividend coverage after incentive-fee waivers normalize.

Evidence & confidence

The filing discloses specific quarterly NII per share ($0.32), NAV per share ($7.95), and a $0.25 dividend, plus debt retirement and revolver extension, which can affect valuation and risk premium.

Market effects

BDC sector read-through on incentive-fee waivers, NAV trajectory, and credit-risk management via debt refinancing and liquidity buffers.

Limited, primarily US small-cap/income investor sentiment.

Low, as the disclosure is company-specific with no stated global macro linkage.

Counterpoint

CoreWeave-related equity gains and incentive-fee waivers may be less repeatable, so dividend sustainability could be questioned if future NII declines.

Key entities

  • Great Elm Capital Corp.

    Reported 2Q26 financial results, declared a $0.25/share dividend for 3Q26, and strengthened liquidity and debt maturities.

  • GECM (investment adviser)

    Waived incentive fees totaling $0.9 million for the quarter, in addition to prior waivers.

  • CoreWeave-related equity investment

    Contributed realized and unrealized gains and distributions during the quarter.

Related articles

$ALVMed

Autoliv, Inc. Q3 2026 Earnings Call Summary

Autoliv, Inc. reported Q3 2026 earnings, outperforming global light vehicle production by 1%, with strong growth in China and India. The company reiterated flat full-year sales guidance and narrowed adjusted operating margin to ~10.5%. Challenges include raw material and logistics headwinds, but management expects Q4 margin expansion. Autoliv also lowered capital expenditure guidance and noted a slight increase in leverage ratio.

$RDYHigh

Dr. Reddy's Laboratories (RDY) Stock Falls on Q2 2027 Earnings

Dr. Reddy's Laboratories (RDY) reported Q2 2027 earnings with revenue down 8.8% to $903.9M, operating profit down 71.6% to $132.2M, and net income down 40.4% to $96.4M. Cash from operations fell 67.4% to $55.2M. The stock dropped 2.69% in morning trading. Institutional investors showed mixed activity, with some adding and others reducing their positions.

$SLGHighAI 8/10

SL Green Q3 FFO Rises to $122.1M on Manhattan Sales

SL Green reported Q3 funds from operations of $122.1M, up from Q2 and the prior year, driven by sales of two Manhattan properties. Net income rose to $72.2M. Leasing activity slowed in deal count but increased in square footage. Revenue reached $273M, up from previous periods. The company hedged against interest rate increases, mitigating some impact.

$RDYMed

Dr. Reddy's (RDY) Q2 2027 Earnings Call Transcript

Dr. Reddy's reported Q2 2027 earnings with a 52.1% gross margin increase sequentially but a 254 basis point year-over-year decline due to lower Lenalidomide sales. EBITDA margin was 20.6%, and profit after tax was ₹9.25 crores. The company highlighted double-digit growth in North America and emerging markets, new product launches, and strategic partnerships. Operating working capital increased to $1.53 billion, with a net cash surplus of ₹2.5 thousand crores.

$SONMed

Sonoco’s consumer packaging dip offsets industrial gains in Q3

Sonoco reported Q3 2026 net sales of $2.04B, down 4.2% YoY, with a net loss of $732M. Consumer packaging sales fell 2.9% to $1.4B, while industrial packaging rose 5.2% to $646M. CEO Howard Coker cited cost inflation and volume challenges, including higher freight and raw material costs. The company expects flat consumer volumes and slight industrial growth in Q4.